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Abstract
UFM1 is a member of the ubiquitin like protein family. While the enzymatic cascade of UFM1 conjugation has been
elucidated in recent years, the biological function remains largely unknown. In this report we demonstrate that the recently
identified C20orf116 [1], which we name UFM1-binding protein 1 containing a PCI domain (UFBP1), andCDK5RAP3 interact
with UFM1. Components of the UFM1 conjugation pathway (UFM1, UFBP1, UFL1 and CDK5RAP3) are highly expressed in
pancreatic islets of Langerhans and some other secretory tissues. Co-localization of UFM1 with UFBP1 in the endoplasmic
reticulum (ER)depends on UFBP1. We demonstrate that ER stress, which is common in secretory cells, induces expression of
Ufm1, Ufbp1 and Ufl1 in the beta-cell line INS-1E.siRNA-mediated Ufm1 or Ufbp1knockdown enhances apoptosis upon ER
stress.Silencing the E3 enzyme UFL1, results in similar outcomes, suggesting that UFM1-UFBP1 conjugation is required to
prevent ER stress-induced apoptosis. Together, our data suggest that UFM1-UFBP1participate in preventing ER stress-
induced apoptosis in protein secretory cells.
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Introduction
Ubiquitin is a small (8.5 kDa) protein, which is evolutionary
conserved in eukaryotes. The so-called post-translational modifi-
cation ‘ubiquitilation’ is the covalent binding of ubiquitin to a
substrate protein. The best-known function of ubiquitilation is the
targeting of proteins for degradation by the proteasome. However,
ubiquitilation can also affect subcellular localization, interactions,
stability or activity of the substrate protein [2]. Therefore,
ubiquitin can participate in a wide variety of cellular processes.
Besides ubiquitin, a large family of ubiquitin-like proteins (Ubls)
has been identified. These proteins do not necessarily share a high
degree of sequence similarity to ubiquitin, but they all contain the
typical ubiquitin-like tertiary structure [3].
Ubiquitin-fold modifier 1 or UFM1 has recently been identified
as a novel protein-conjugating system, displaying a similar tertiary
structure to ubiquitin [4]. To be activated, UFM1 is processed C-
terminally by two specific proteases, UfSP1 and UfSP2 [5,6]. After
processing, UFM1 is activated via the E1 enzyme, UBA5, and
then conjugated by the E2 enzyme, UFC1. UFL1 has very
recently been identified as the E3 enzyme and C20orf116 as a
substrate of UFM1 [1]. However, cellular functions associated
withtarget proteins that aremodified by UFM1 are still unknown.
The pancreatic beta cell is unique in its capacity to synthesize,
store and secrete insulin with precise rates to cover the metabolic
needs of the organism [7]. The fine-tuning of insulin synthesis,
storage and secretion is regulated at many levels of gene
expression, ranging from transcription, mRNA stability to
translation and folding [8]. Microautophagic activity also plays a
role in maintaining cellular hormone stores to optimal levels [9].
To fulfill this heavy task of insulin biosynthesis, the beta cell has a
highly developed endoplasmic reticulum (ER). Optimal function-
ing of the ER is essential for proper protein folding and cell
survival. Any disturbance in ER folding needs and capacity leads
to ER stress and activation of the ER stress response (also called
unfolded protein response) [10,11,12,13]. The aim of this response
is to restore ER homeostasis and at least three functionally dis-
tinct responses have been identified. First, up-regulation of ER
chaperones to increase protein folding activity and to prevent
protein aggregation [14]. Second, attenuation of global protein
translation to reduce the load of newly synthesized proteins and
prevent excessive accumulation of unfolded proteins [15,16].
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        Finally, degradation of proteins misfolded in the ER, which is
called ER-associated degradation (ERAD) [17]. Three ER stress
transducers can be recognized: IRE1, ATF6 and PERK
[15,18,19]. IRE1 induces Xbp1 splicing, which in turn, together
with ATF6, induces transcription of chaperones (e.g. BiP), genes
involved in ERAD and CHOP. In parallel, PERK activation upon
ER stress increases eIF2a phosphorylation, which on the one hand
inhibits protein translation and on the other hand activates
transcription of chaperones, genes involved in ERAD and CHOP.
When this ER stress response fails to restore ER homeostasis,
apoptosis is triggered [20].
The link between ER dysfunction and diabetes has been studied
extensively. PERK null mice have increased beta cell apoptosis
and early onset diabetes [21], eIF2a
S51A heterozygous mice
develop diabetes when fed a high fat diet [22], and CHOP
2/2mice
haveimprovedbetacellfunctionandbettercellsurvivalinconditions
that cause diabetes in control mice [23]. The conservation of these
regulatorypathwaysamongvertebratesandthelinkbetweenPERK
mutations and diabetes in patients with the Wolcott-Rallison
syndrome [24] indicate that ER stress is important for diabetes in
humans (reviewed in [11]).
In the present study we have investigated the UFM1 pathway in
rodent pancreatic beta cells using both mouse isolated islets and
the cell lines INS1 and MIN6. Our results show thatUFM1 and its
target UFBP1are highly expressed in the pancreatic islets of
Langerhans, and that their expression is increased upon ER
stress.We provide evidence that UFM1 and UFBP1are important
for the prevention of ER stress-induced apoptosis.
Results
Ufm1 is highly expressed in pancreatic islets of
Langerhans
Both in microarray mRNA expression analysis in the mouse
(Figure 1A)and via quantitative real-time PCR, using Ufm1-specific
primers and probe (Figure S1)the transcript encoding Ufm1
(Ubiquitin-fold modifier 1) was found to be very abundant in
protein-secreting cells, especially pancreatic acini, islets of
Langerhans and salivary glands. Furthermore, Ufm1 mRNA levels
in islets were higher in fed mice, as compared to mice that were
fasted for 20 hours (Figure 1B). A similar tissue distribution was
observed at the protein level, using a UFM1-specific antibody
(Figure 1C). Not only free UFM1 could be detected, but also
several UFM1 conjugates. From this tissue expression profile we
hypothesized that UFM1 plays an important role in protein
secreting cells like beta cells in the islets of Langerhans.
Figure 1. Expression profile of Ufm1 in differentmouse tissues. A Ufm1 mRNA expression in 19 different mouse tissues and MIN6 cells,
measured via microarray (probe set 1449263_at), n$3, B Ufm1 mRNA expression in islets from mice which were fasted for 20 hours or fed a normal
diet, n$3, * p=0.02, C UFM1 protein expression in the same mouse tissues. Immunodetection was done with a UFM1 specific antibody. Both free
UFM1 (r) and UFM1 conjugates (*) are shown. An equal amount of protein was loaded on gel. Both GAPDH and b-actin were used as control, since
no protein is equally expressed in all tissues. Representative immunoblot is shown.
doi:10.1371/journal.pone.0018517.g001
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CDK5RAP3 and UFL1
To identify the target(s) of UFM1, we performed a UFM1
affinity purification. We engineered a STrEP-tag at the N-
terminus of UFM1and transfected clonal insulin-producing MIN6
cells with this STrEP-Ufm1 construct. We exposed the cells for
2 hours to 10 mg/l cycloheximide to increase UFM1 conjugation
(see below). STrEP-UFM1 was affinity purified and the eluates
were analyzed via SDS-PAGE and coomassie staining (Figure
S2A). In total, 9 protein fragments were eluted from gel and
further analyzed via mass spectrometry (Table 1). We identified
the conjugating enzyme UFC1 in the,20 and ,36 kDa fragment
and the activating enzyme UBA5 in the ,45 kDa and ,60 kDa
protein fragments [4]. Also the very recently reported ligating
enzyme UFL1 (,100 kDa fragment; 1810074P20Rik) and the
substrate C20orf116 (,40 kDa fragment; 2600009E05Rik) [1]
were picked-up in this screen. CDK5RAP3/LZAP (,60 kDa
fragment), two heat shock proteins HSPA8 and HSPA5 (BiP)
(70 kDa fragment) and pyruvate carboxylase (,130 kDa) were the
other identified proteins. The isolation of pyruvate carboxylase is
perhaps not surprisingly since it is biotinylated and highly
expressed in beta cells [25].
The interactions between the identified proteins and UFM1
were further analyzed by GST pull down. A GST-tag was coupled
to the N-terminus of mouse UFM1 with a C-terminal ending
glycine residue (GST-UFM1(G)). Purified GST-UFM1(G) and
GST protein were coupled to glutathione-agarose beads and
incubated with
35S-labeled mouse 2600009E05Rik/C20orf116,
CDK5RAP3, BiP and 1810074P20Rik /UFL1, which were
generated by T7 invitro transcription/translation. 2600009E05Rik
and CDK5RAP3 were recovered from the GST-Ufm1(G) coupled
beads, but not from the GST coupled beads (Figure 2A).
Therefore, we propose to name 2600009E05Rik/C20orf116a-
sUFBP1, or UFM1 binding protein 1 containing a PCI domain.
Although very weak, the interaction between UFM1 and UFBP1
was also confirmed via co-immunoprecipitation with a UFBP1 and
UFM1 specific antibody (Figure 2B). Neither BiP nor UFL1 could
bind to GST-UFM1(G) or GST coupled beads, indicating that
they do not interact directly with UFM1. Co-immunoprecipitation
with a BiP or UFM1 specific antibody could also not demonstrate
a binding between UFM1 and BiP (Figure 2B). However, an
interaction between UFBP1 and BiP was observed after co-
immunoprecipitation with a UFBP1 specific antibody (Figure 2B).
To analyze why UFL1 did not bind in our in vitro screen, we used
the same GST pull down strategy, using CDK5RAP3-GST as
bait. Figure 2A shows an interaction between CDK5RAP3 and
UFL1, but not with UFBP1. These results show that UFM1
directly binds (covalent or non-covalent) to UFBP1 and
CDK5RAP3, and that UFL1 binds to CDK5RAP3 (Figure 2C).
Recently, the interaction between UFL1 and CDK5RAP3 was
also demonstrated by some other groups [26,27,28].
We also analyzed the mRNA expression of the different
interacting partners of UFM1 in a mouse tissue panel via
microarray (Figure 3). While Ufbp1 mRNA expression levels were
rather homogenous in the different mouse tissues, the protein
UFBP1 showed the highest expression in pancreatic islets, followed
by pancreatic acini and testis. Ufl1 showed the highest expression
in the pancreatic islets, followed by some other secretory tissues
e.g. seminal vesicle and salivary gland and Cdk5Rap3 was highest
expressed in salivary gland and testis, followed by seminal vesicle,
pituitaryand pancreatic islets.
UFBP1 is, like UFM1, evolutionary conserved. The protein is
present in plants, invertebrates and vertebrates (Figure 2D).
Detailed computational analysis of the UFBP1 protein (314 aa)
sequence and structure revealed the presence of a signal peptide
for the ER (aa 1–28), a transmembrane helix (aa 5–22), a nuclear
localization signal (aa 65–69) and a PCI domain (aa 229–273)
[29]. PCI domains are present in several regulatory Proteasome
subunits, COP9 subunits, eIF3 translation initiation factor
subunits, and in certain other multi-protein complexes [30]. To
investigate the role of these two domains in the binding
with UFM1, we performed a new GST-pull down experiment.
We first constructed aUfbp1 construct without the signal
peptide, UFBP1
29–314, or without the PCI domain, UFBP1
1–219.











1 UFM1; Ubiquitin fold modifier 1 P61961 9 2 2 31.8 ER stress-induced apoptosis (this paper)
2 UFC1; Ufm1-conjugating enzyme 1 Q9CR09 20 3 2 10.8 E2 enzyme of UFM1 (Komatsu et al, 2004)
3 UFC1; Ufm1-conjugating enzyme 1 Q9CR09 20 2 1 6 E2 enzyme of UFM1 (Komatsu et al, 2004)
4 UFBP1; Ufm1 binding protein
containing a PCI domain
Q80WW9 36 4 3 13.3 ERAD/ER stress-induced apoptosis, target
of UFM1 (Tatsumi et al, 2010; this paper)
5 UBA5; Ubiquitin-like
modifier-activating enzyme 5




Q8VE47 45 2 2 5.2 E1 enzyme of UFM1 (Komatsu et al, 2004)
CDK5RAP3; CDK5 regulatory
subunit-associated protein 3
Q99LM2 57 4 3 6.4 tumor suppressor (Wang et al, 2007);
substrate of Ufm1 (this paper)
7 HSPA5/BiP; 78 kDa
glucose-regulated protein precursor
P20029 72 3 3 4.7 ER stress, chaperone (Ma, Hendershot,
2004)
HSPA8; Heat shock 70 kDa protein 8 P63017 71 5 5 8 chaperone (Zimmerman, 1998)
8 Ufl1; UFM1 ligation protein Q8CCJ3 100 7 7 9.7 E3 enzyme of UFM1 (Tatsumi et al., 2010,
this paper)
9 PCX;Pyruvate carboxylase Q05920 130 12 11 12.3 anaplerosis//cataplerosis (Fransson et al,
2006)
doi:10.1371/journal.pone.0018517.t001
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29–314 (without the signal peptide) and
UFBP1
1–219 (without the PCI domain) were generated by T7
invitro transcription/translation. Figure 2A shows that both
truncated proteins could still bind to UFM1 in vitro, showing that
neither the signal peptide nor the PCI domain is required for the
interaction between UFM1 andUFBP1.
To clarify if the UFM1/UFBP1-interaction is covalent or
non-covalent, we first performed a STrEP-tag affinity purifica-
tion with UFBP1_STrEP, similar to the affinity purification with
STrEP_UFM1. The eluates were also analysed via SDS-PAGE
and Coomassie staining (Figure S2B). Three distinct protein
fragments (,38, ,41 and ,50 kDa) were identified as UFBP1.
Interestingly, the protein fragment of ,50 kDa was about 10 kDa
too high for UFBP1 and missed the peptides containing the
unmodified K268. The ,10 kDa shift is in perfect agreement with
a UFM1 modification (+9.1 kDa) of UFBP1 and lysine K268
being involved in UFM1 conjugation with UFBP1 is in agreement
with previous published data [1]. In a second approach, we
performed cellular fractionation of MIN6 lysates and Figure 2E
clearly shows that the UFM1 conjugate of about 40 kDa was at the
same height and showed the same cellular localization as UFBP1.
In addition, overexpression of UFBP1_eGFP, resulted in a UFM1
conjugate of ,70 kDa (Figure S2C). Surprisingly, also overex-
pression of UFBP1
K268R-eGFP resulted in a UFM1 conjugate of
Figure 2. UFM1 interacts with UFBP1 and CDK5RAP3. A GST pull down (UFM1(G) and CDK5RAP3) with in vitro T7 transcribed/translated
35S-labelled UFBP1, UFBP1
29–314, UFBP1
1–219 CDK5RAP3, UFL1 and BiP. Lane 1 shows the starting labeled proteins used for the pull down experiment
(input) and a schematic overview of the used UFBP1 constructs. A GST-antibody was used for immunoblotting (WB), B co-immunoprecipitation with
BiP, UFL1 and UFM1 specific antibodies, C Schematic overview of the protein interactions of UFM1 demonstrated in mouse in this manuscript,
D Evolutionary conservation of UFBP1 (2600009E05Rik). Protein sequence in Mm (Musmusculus), Rn (Rattusnovergicus), Hs (Homo sapiens),
Dr (Daniorerio), Gg (Gallus gallus), Tn (Tetraodonnigroviridis), Fr (Fuguribripes), Ag (Anopheles gambiae), Ce (Caenorhabditiselegans), Dm (Drosophila
melanogaster) and At (Arabidopsis thaliana). Alignment was performed using ClustalW. The signal peptide of UFBP1 is boxed in grey, the nuclear
localization signal is depicted in green, the PCI domain is boxed in black and lysine268 (K268) is shown in red, E Presence of UFM1 conjugates at the
same height and with the same cellular localization as UFBP1 (*). MIN6 cell lysates were separated in 5 different fractions: N=nuclear and whole cell
fraction (7706g), M=heavy mitochondrial fraction (23306g), L=light mitochondrial, peroxisomal and lysosomal fraction (13,0006g), P=cell
membrane fraction (100,0006g) and S=cytosolic and large protein complexes supernatant (100,0006g).
doi:10.1371/journal.pone.0018517.g002
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covalent to UFBP1 and that K268 is involved, but not required for
this binding.
Translocation of UFM1 to the ER depends on UFBP1
Different eGFP and mRFP fusion constructs were made and
transfected into INS1-832/13 cells, to analyze the cellular
localization of UFM1 and UFBP1 via fluorescence microscopy.
After overexpression, UFM1 was equally localized in the
cytoplasm and the nucleus (Figure 4A). Overexpression of full
length UFBP1-eGFP showed an ER-specific expression. Deletion
of the PCI domain of UFBP1 had almost no effect on the
localization of the protein, while deletion of the signal peptide
resulted in an exclusive nuclear localization (Figure 4A). When we
overexpressed mRFP-UFM1 and UFBP1-eGFP together, UFBP1
remained localized in the ER, but UFM1 was no longer equally
distributed over cytoplasm and nucleus (Figure 4B,D). Instead, it
was more localized in the ER, indicating that overexpression of
UFBP1 influences the localization of UFM1. A similar localization
patternwas observedincellswheremRFP-UFM1andUFBP1
1–219-
eGFPwere co-expressed (Figure 4D,Figure S3B). Overexpression of
UFM1 together with UFBP1
29–314, which is truncated for the signal
peptide, however, resulted primarily in a nuclear localization of
UFM1 (Figure 4D, Figure S3B). The same results were obtained
after overexpression of these constructs in human HeLa cells
(Figure 4C, Figure S3A), indicating that UFM1 and UFBP1
localization is similar in mouse and human. Next we overexpressed
the mutants UFBP1
K268R and UFM1
G83A in INS1 cells. Processing
of UFM1 to its mature form is significantly reduced in the
UFM1
G83A mutant [1]. Both mutants showed a similar localization
as their WT counterpart (Figure S4A and results not shown).
Overexpression of mRFP-UFM1 and UFBP1-eGFP in INS1 cells
resulted in 3464% of the cells in co-localization of UFM1 and
UFBP1 in the ER. When the mutant UFBP1
K268R-eGFP was
overexpressed together with WT UFM1, we found co-localization
in 3362% of the cells, which is similar with WT UFBP1. After
co-transfection of UFM1
G83A-mRFP and UFBP1-eGFP or
UFBP1
K268R-eGFP, the amount of cells with co-localization of
the two proteins was significantly increased (7067%; p=0.006 and
6066%; p=0.02, respectively, n=4) (Figure S4B), compared to
overexpression of the WT proteins.
To ensure that overexpression did not cause a mislocalization
of the proteins, we also detected the cellular localization of
endogenous UFM1 and UFBP1 via cellular fractionation. It is
clear that UFBP1 was present in the same fraction as BiP,
indicative for ER localization (Figure 4E). UFM1 partially co-
localized with UFBP1 in the ER, but a significant amount of
UFM1 protein was detected in the cytosolic fraction, which
contains both cytosolic proteins and large protein complexes.
Overexpression of UFM1 did not change the localization of
UFM1, still cytoplasmic and ER (Figure 4F). In contrast, when
UFBP1 or both, UFM1 and UFBP1 were overexpressed, UFM1
was mainly expressed in the ER (Figure 4F), similar to what we
observed via immunocytochemistry. Overexpression of
UFM1
G83A resulted in a wrong localization when not processed,
but a normal localization was observed when processed (Figure 4F,
upper and lower band respectively). However, via fluorescence
microscopy, UFM1 and UFM1
G83A showed the same localization
and UFM1
G83A was still partially co-localized in the ER when
overexpressed with UFBP1 (Figure S4).
These data indicate that UFBP1 and UFM1 are partially co-
localized in the ER and that UFBP1 plays an important role in the
compartmentalization of UFM1 in the cell. We also show that the
PCI domainof UFBP1, containing lysine K268, and glycine G83
of UFM1 are not required for this co-localization, suggesting that
Figure 3. mRNA expression of Ufbp1, Ufl1 and Cdk5Rap3 in 23 different mouse tissues and MIN6 cells, measured via microarray
(probe set 1434702_at, 1429008_at and 1423067_at, respectively). UFBP1 protein expression measured in the same tissue panel. A UFBP1
specific antibody was used, and the same amount of protein was loaded as in Figure 1C.
doi:10.1371/journal.pone.0018517.g003
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responsible for the co-localization in the ER.
UFM1 and UFBP1 are not involved in glucose stimulated
insulin secretion
Based on the expression profile of UFM1and its cellular
localization, we hypothesized that UFM1 could play a role in
the secretory pathway of protein secreting cells. To address this,
we investigated the role of UFM1 and UFBP1 on insulin secretion
in the rat glucose-responsive insulinoma cell line INS1-832/13.
The effect of Ufm1 specific RNAi mediated silencing on glucose-
stimulated insulin release was examined 48 hours after transfec-
tion of 832/13 cells with aUfm1-o rUfbp1-specific siRNA duplex
or a control duplex (siControl) with no known sequence homology.
Treatment with the Ufm1 or Ufbp1siRNA duplex caused
respectively a ,60% or 80% decrease in Ufm1 or Ufbp1 mRNA
levels compared to siControl-treated cells; the efficiency of knock-
down did not increase after 72 hours of incubation (data not
shown). Insulin release in these silenced cells was not affected
compared to the control cells (Figure S5), indicating that neither
UFM1 nor UFBP1 are required for glucose regulated insulin
secretion.
ER stress-induced apoptosis is increased after Ufm1,
Ufbp1 and Ufl1 knockdown
Since UFM1 and UFBP1 are co-localized in the ER and a
possible effect of ER stress on Ufm1 expression was suggested
[31,32], we analyzed the role of UFM1 and UFBP1 during ER
stress. A 14-hour exposure of INS-1E cells to cyclopiazonic acid
(CPA), a potent ER Ca
2+ ATPase pump inhibitor and pharma-
cological inducer of ER stress, markedly induced Ufm1 and Ufbp1
mRNA expression (Figure 5A,B). This induction was confirmed
at the protein level (Figure 5D). The chemical ER stressors
thapsigargin (another inhibitor of the ER Ca
2+ ATPase pump) and
Figure 4. UFBP1 and UFM1 are co-localized in the ER. A INS1-832/13 cells transfected with different eGFP constructs as indicated on the
picture. INS1-832/13 cells (B) and Hela cell (C) co-transfected with mRFP-UFM1 and UFBP1-eGFP, D Overview of INS1-832/13 cells co-transfected with
mRFP-UFM1 and UFBP1-eGFP, UFBP1
29–314-eGFP or UFBP1
1–214-eGFP, as depicted. Cells were also stained with an ER-tracker (blue). Pictures were
taken with a 636objective on a Zeiss confocal microscope, E UFM1 and UFBP1 expression in different MIN6 cellular fractions, similar as in Figure 2E.
Different cellular markers were used: GDH, mitochondrial marker; LAMP2, lysosomal marker; BiP, ER marker and HSPA8, cytosolic marker. F UFM1
expression after cellular fractionation of MIN6 cells overexpressing UFM1, UFBP1, both UFM1 and UFBP1 or UFM1
G83A, as depicted (*, unprocessed;
‘, processed).
doi:10.1371/journal.pone.0018517.g004
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Ufm1 and Ufbp1mRNA , while cyclohexamide and H2O2, two
non-ER stressors, had no influence on the expression
levels(Figure 5A,B), suggesting that ER stress mediates the
upregulation. Free fatty acids (FFAs) are physiologically more
relevant ER stress inducers in beta cells [33,34,35]. Exposure of
INS-1E cells to the FFAs oleate or palmitate for 14 hours did not
increase Ufm1 expression (Figure 5A), but Ufbp1 was clearly
induced (Figure 5B). Also the expression of Ufl1, the E3 enzyme of
UFM1, was increased after ER stress, similar to Ufm1 and Ufbp1
expression (Figure 5C).
The effect of ER stressors on UFM1 conjugation was also
analyzed. Figure 5E shows a clear reduction of UFM1-UFBP1
conjugation after ER stress. The reduction in conjugation was not
a consequence of increased proteasome activity since the
conjugates also decreased after treatment of the cells with
MG115, a potent proteasome inhibitor (Figure 5E). In contrast,
decreasing the ER load via translational inhibition with cyclohex-
imide resulted in an increase in UFM1-UFBP1 conjugation. These
data suggest that UFM1-UFBP1 conjugation depends on the
protein load in the ER, high when protein load is low and low
when protein load is high.
Because apoptosis is triggered when the ER stress response fails
to restore ER homeostasis, we analyzed the effect of a reduced
Ufm1andUfbp1 expression on beta cell survival. We analyzed also
the effect of Ufl1 knockdown on apoptosis, to be able to investigate
the importance of the conjugation between UFM1 and UFBP1,
since a reduced UFL1 expression results in a significant reduction
of UFM1-UFBP1 conjugation [1]. The knockdown efficiency
during the whole experiment is shown in Figure S6.Ufm1silencing
had no effect on basal apoptosis, but significantly increased
apoptosis upon ER stress induced by palmitate, CPA and brefeldin
A compared to siControl cells (Figure 6A). Ufbp1 silencing
increased oleate-, palmitate- and brefeldin A-induced apoptosis
(Figure 6B) and Ufl1 silencing increased CPA- and brefeldin A-
induced apoptosis by 30–40% compared to siControl treated cells
(Figure 6C). Ufm1 and Ufbp1 silencing had no affect on apoptosis
induced by non-ER stressors such as cycloheximide- or H2O2
(Figure 6A, B), indicating that these proteins specifically act on ER
stress-induced apoptosis. The sensitization of beta cells to ER
stress-induced apoptosis was confirmed using a second method,
namely caspase 3 cleavage. The knockdown of Ufm1 and Ufbp1
lead to enhanced caspase activation by CPA and brefeldin A
(Figure 6D). Although Ufbp1 and Ufm1 silencing sensitized beta
cells to ER stress, the expression of BiP, Chop or spliced Xbp1 was
not altered (Figure S7).
These data show that Ufm1 and Ufbp1 expression is upregulated
upon ER stress, while UFM1-UFBP1 conjugation is decreased
under these conditions; furthermore, UFM1 and UFPB1 are
needed to prevent beta cell apoptosis caused by accumulation of
unfolded protein in the ER.
Discussion
In this study we provide evidence for a role of UFM1 and
UFBP1in ER stress-induced beta cell apoptosis. We also identified
Figure 5. Ufm1, Ufbp1and Ufl1 expressionis induced upon ER stress. A mRNA expression level of Ufm1 (A), Ufbp1(B) or Ufl1 (C) after exposure
of INS-1E cells to 25 mM CPA, 1 mM thapsigargin, 1 mg/ml brefeldin A, 5 mg/ml cycloheximide, 30 mMH 2O2, 0.5 mMoleate and 0.5 mMpalmitate for
14 hours, measured via qPCR and normalized for GAPDH (Ufm1 and Ufbp1) or actin (Ufl1). Data are means6SEM, n=4–6, *, p#0.05; **, p#0.01, paired
student t-test, D UFM1 and UFBP1 protein expression is induced in cells exposed for 14 hours to CPA. Actin is shown as a control for protein loading,
E UFM1-UFBP1 conjugates. Incubation of MIN6 or INS1 cells with ER stressors (25 mM CPA, 14h, INS1 cells; 1 mM thapsigargin (Tg), 1h, MIN6 cells) or
proteasome inhibitor (100 mM MG115, 2h, INS1 cells) decreased conjugation, while incubation with a translational inhibitor (10 mg/l cycloheximide
(CHX), 2h, MIN6 cells) increased the conjugate formation. *=UFM12UFBP1 conjugate, 10 kDa=free UFM1.
doi:10.1371/journal.pone.0018517.g005
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LZAP.
Eight UFM1 interacting proteins were isolated and identified
via affinity purification and mass spectrometry (UFC1, UFBP1,
UBA5, CDK5RAP3, HSPA8, BiP, UFL1 and PC). For two of
these, UFBP1 and CDK5RAP3, the interaction could be
confirmed in vitro by GST pull down. Two expected UFM1
interacting proteins (UBA5 and UFC1, the known activating and
conjugating enzymes of human UFM1 [4]) were identified.
However, each of these two proteins was identified ashaving two
distinct molecular masses. This could be explained by the fact that
during denaturation of the protein extracts, the interaction
between UFM1 and UBA5 or UFC1 was partially sustained.
The screen also identified pyruvate carboxylase, but this is likely to
be an artifact since the STrEP-tag affinity purification is based on
streptavidin-biotin binding and pyruvate carboxylase has biotin as
a natural co-factor. Moreover, pyruvate carboxylase protein is
very abundant in beta cells [25]. Interestingly, the important ER
chaperoneBiPwhich is known to play an important role in the
unfolded protein response of protein secreting cells [36] and in
particular for pro-insulin folding in the pancreatic beta cell [22,37]
interacted with UFM1 in our screen.While we could not confirm
this interaction in GST pull down experiments and co-immuno-
precipitations, we found an interaction between UFBP1 and BiP
after co-immunoprecipitation.
In a large scale mapping of human protein-protein interactions
by immunoprecipitation and mass spectrometry, Ewing et al.
provided evidence for an interaction of CDK5RAP3 with UFM1,
UFC1, UFL1 and UFBP1 [38]. Since we found an interaction of
mouse UFM1 with the same proteins, this suggests that a similar
complex exists both in mouse and human. Although we could not
confirm the interaction between UFM1 and UFL1 via GST pull
downs in vitro, these data, together with our finding that UFL1
interactsin vitro to CDK5RAP3, suggest that UFL1 is part of the
complex, but that it has no direct interaction with UFM1. Tatsumi
et al. reported that UFL1 is an E3 ligase for UFM1, although it has
no structural characteristics of the typical E3 enzymes [1]. They
found an interaction between UFM1-UFL1, UFL1-UFC1 and
UFM1-C20orf116, using immunoprecipitations. Since under these
conditions, also all other proteins (e.g. CDK5RAP3) are present, it
is possible that the interaction between UFM1 and UFL1 is
indirect, as shown in our experiments. Another possibility is that
under our GST-pull down conditions, the required environment
for interaction was not created, although we do see an interaction
Figure 6. UFM1 and UFBP1 are involved in ER stress induced apoptosis. INS-1E cells were treated with the ER stressors oleate, palmitate,
cyclopiazonic acid (CPA) and brefeldin A or the ER stress-independent apoptosis inducers cycloheximide and H2O2, and silenced forUfm1 (A), Ufbp1
(B) or Ufl1 (C). Apoptosis was evaluated by Hoechst/PI staining. Data are means6SEM of 3–7 independent experiments. Paired student t test:
*, p#0.05; **, p#0.01; ***, p#0.001 compared to control treatment; #,p #0.05; ##,p #0.01 silenced cells compared to siControl cells, D Caspase 3
activation in Ufm1 and Ufbp1 silenced cells after treatment with the ER stressors CPA and brefeldin A (Bref). The densitometric quantification of the
immunoblots is shown in the lower panel. Cleaved Caspase-3 signal was normalized for a-tubulin expression. The results are means 6 SEM of 2–3
independent experiments. In the assays, the respective controls contain the vehicles ethanol and DMSO.
doi:10.1371/journal.pone.0018517.g006
Role of UFBP1 and UFM1 during ER Stress
PLoS ONE | www.plosone.org 8 April 2011 | Volume 6 | Issue 4 | e18517between UFL1 and CDK5RAP3 under these conditions. An
interaction between UFL1 and CDK5RAP3 was recently also
shown by some other groups [26,27,28]. The covalent binding
between UFM1 and UFBP1 is supported by the MS/MS
identification of UFBP1 in a protein fragment which is about
10 kDa higher than the predicted molecular weight of UFBP1,
and which contains a modified lysine 268. The increase in
molecular weight is in perfect agreement with a UFM1
modification (,9.1 kDa). Also the presence of a UFM1 conjugate
at the same height and with the same cellular localization as
UFBP1 supports the covalent binding.
Detailed analysis of the protein sequence of UFBP1 revealed the
presence of a signal peptide, a nuclear localization signal and a
PCI domain [29]. Based on the presence of this signal peptide,
UFBP1 is predicted to play a role in the secretory pathway (Target
P1.1 prediction, [39]). Deletion of the signal peptide did not
prevent the binding between UFM1 and UFBP1 in vitro but it
prevented the ER localization of both UFBP1 and UFM1. Both
proteins were mainly localized in the nucleus when the signal
peptide was deleted, which could be explained by the presence of a
nuclear localization signal in UFBP1. The function of this nuclear
localization signal seemed to be overruled by the signal peptide,
since the full length protein is localized in the ER. UFBP1 also
contains a PCI domain, an alpha-helical domain of about 200
residues, which is generally localized at the C-terminus of the
protein [30]. The COP9 signalosome is a conserved eight-subunit
complex, which can physically associate with the 26S proteasome,
and may function as an alternate lid for the proteasome [40]. A
PCI domain can serve as a structural scaffold for multi-protein
complexes or proteasome regulators. However, deletion of the PCI
domain resulted in a stronger interaction between UFM1 and
UFBP1, compared to the interaction with the full length UFBP1.
Furthermore, UFBP1
1–219 co-localized even stronger with UFM1
to the ER than UFBP1 did. We analyzed several conserved lysine
residues (K121/K122, K192/K194 and K159) outside the signal
peptide and PCI-domain via GST pull down, but none of these
lysine residues seemed to play a role on their own for interaction
with UFM1 (results not shown).K268 may not be the only lysine
residue involved in UFM1 conjugation since the mutants
UFBP1
K268R and UFBP1
1–219 are still able to form UFM1
conjugates. Our interpretation is that while K268 is the main
lysine residue for conjugation, but when this residue is deleted,
other lysine residues can take over. Most likely, UFM1 can interact




1–219 can still co-localize in
the ER. However, we cannot exclude that endogenous UFM1 and
UFBP1 play a role in this co-localization (e.g. via dimerization).
Another possibility is that overexpression of UFBP1 caused
changes in the ER (e.g. massive amplification of ER network as
recently reported [1]), and that these changes had an influence on
the localization of UFM1.
Since UFBP1 was predicted to function in the secretory
pathway and UFM1 is mainly expressed in secretory cells, we
analyzed the effect of Ufm1 and Ufbp1 silencing on the glucose
stimulated insulin release. However, no clear effect of decreased
UFM1 and UFBP1 protein levels on insulin release was observed.
Also no secreted UFBP1 could be detected in the medium (results
not shown).
We showed that Ufm1, Ufbp1and Ufl1 expression in INS1 cells
was increased upon ER stress induced by chemical ER stressors
and by the FFAs palmitate and oleate, fitting with other data
[31,32]. The protein synthesis/folding load in the ER had a strong
influence on the amount of detected UFM1-UFBP1 conjugates:
increasing the protein load with ER stressors (cyclopiazonic acid,
thapsigargin) decreased the abundance of conjugates, while a
decrease in protein load with the translational inhibitor cyclohex-
imide increased UFM1-UFBP1 conjugation. One possible inter-
pretation is that UFM1-UFBP1 conjugates are used during protein
folding in order to prevent ER stress and beta cell apoptosis. A
difference in conjugate stability under different conditions could be
the reason why after cycloheximide treatment the amount of
conjugates increased, while free UFM1 protein and Ufm1 mRNA
levels stayed the same. Apoptosis induced by non-ER stressors was
not influenced by the knockdown of UFM1 or UFBP1. The fact
that Ufl1 knockdown also enhanced apoptosis, similar to Ufm1 and
Ufbp1 silenced cells, suggests that it is the conjugation between
UFM1 and UFBP1 that is required, rather than the expression of
the proteins itself. The exact mechanism how UFM1-UFBP1
conjugation can protect the cell is not known. Although Ufbp1 and
Ufm1 silencing sensitized beta cells to ER stress, the expression of
BiP, Chop or spliced Xbp1 was not altered (Figure S7). However, we
did see an impairment of ERAD activity upon Ufbp1 knockdown
(Figure S8).
Importantly, in a recent study, Lu et al. identified UFM1 as a
potential factor associated with the development of type 2 diabetes
[41]. UFM1 expression was 1.94 (protein) and 1.53 (mRNA) times
higher in MKR mice (Type 2 diabetes model) than in wild type
mice. MKR islets also contain more molecular chaperones
(GRP78 and GRP94) and proteins involved in ERAD [42]. In
light of our present data, this increased UFM1 expression may be
the result of ER stress in beta cells in vivo, and might be part of a
protective response.
CDK5RAP3/LZAP is a putative tumor suppressor, as it was
shown to activate the tumor suppressor p53 and to inhibit growth
of tumor cell lines in vitro [43]. Furthermore, CDK5RAP3
promotes apoptosis in response to genotoxic agents [44] and is
an inhibitor of NF-kB [45]. Very recently, Shiwaku et al.
demonstrated that UFL1 (Maxer) is also anchored in the ER
and interacts with its N-terminal cytosolic part to CDK5RAP3.
With this interaction, UFL1 prevents CDK5RAP3 to inhibit cyclin
D1 expression, required for G1/S transition. Further experiments
are necessary to clarify the role of the interaction between UFM1
and CDK5RAP3 in the cell.
In summary our study shows that UFM1-UFBP1interaction
occurs primarily in protein secreting cells like pancreatic beta cells;
in such cells this interaction may protect the cells against ER stress
and apoptosis.
Materials and Methods
Tissue isolation, cell culture and transient transfection
All procedures involving mouse tissues were conducted according
to protocols and guidelines approved by the K.U. Leuven animal
welfare committee (ID 085/2003).Mouse tissues were isolated from
male C57Bl/6J mice, between 12 and 15 weeks old. Islets were
isolated by injection of collagenase P (Roche) in the pancreatic duct
followed by 3 min digestion at 37uC. Islets were hand-picked in
HEPES Krebs buffer (20 mM HEPES, pH 7.4; 119 mMNaCl;
4.75 mMKCl; 2.54 mM CaCl2; 1.2 mM MgSO4; 1.18 mM
KH2PO4; 5 mM NaHCO3) containing 5 mM glucose, and used
directly for RNA or protein isolation. The mouse insulin-producing
MIN6 cell line (p. 20–30) was kindly donated by Dr. E. Yamato
(Osaka University, Japan) [46] and cultured in DMEM (Invitrogen)
(25 mM glucose) equilibrated with 5% CO2 and 95% air at 37uC.
The medium was supplemented with 15% decomplemented fetal
calf serum(FCS, Invitrogen), 70 mMb-mercaptoethanol, 4 mMglu-
taMAX, 50 U/ml penicillin and 50 mg/mlstreptomycin. The
rat insulin-producing INS1-832/13 cell line (p. 50–70) [47] was
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decomplemented FCS, 1 mM sodium pyruvate, 50 mM b-mercap-
toethanol, 10 mM HEPES, 100 U/ml penicillin and 100 mg/ml
streptomycin. The rat insulin-producing INS-1E cell line (p. 55–75)
(a kind gift from Dr. C. Wollheim, Centre Medical Universitaire,
Geneva, Switzerland) was cultured in RPMI 1640 (with Gluta-
MAX-I) containing 5% FCS, 10 mM HEPES, 1 mM sodium
pyruvate, 100U/ml penicillin, 100 mg/ml streptomycin and 50 mM
2-mercaptoethanol [48]. The mouse glucagon-producing aTC1-6
cell line [49] was cultured in DMEM/F12 medium supplemented
with 10% decomplemented FCS, 25 mM glucose, 50 U/ml
penicillin and 50 mg/ml streptomycin. Treatment of INS1 cells
with oleate and palmitate (sodium salt, Sigma), cyclopiazonic acid
(CPA, 25 mM, Sigma), thapsigargin (1 mM, Sigma), brefeldin A
(1 mg/ml, Sigma), cycloheximide (5 mg/ml) or H2O2 (30 mM)were
performed as described before [50]. For the free fatty acid (FFA)
treatment, medium was used containing 1% FCS and 1% charcoal-
absorbed BSA. FFAs were dissolved in 90% ethanol and diluted
1:100 to a final concentration of 0.5 mM, corresponding to a FFA/
BSA ratio of 3.4 [50,51].To suppress Ufm1 expression in 832/13
cells, 25 nM of a Ufm1-specific siRNA was transfected, using
Dharmafect 1 (Dharmacon) or Lipofectamine 2000 (Invitrogen),
according to the manufacturer’s protocol. Control cells were treated
with an siRNA with no known sequence homology (siControl), as
previously described [52]. For overexpression experiments in MIN6
cells, AMAXA technology was used. Briefly, 10
7 cells were
electroporated with 5 mg pDNA, using the T20 program, and
recovered for 1 day in RPMI medium. For overexpression in INS1-
832/13 cells, 800K cells in a 6-well were transfected with Fugene
HD (Roche, Switzerland), using a 2 mg/8 ml pDNA/fugene HD
ratio.
RNA isolation and quantitative RT-PCR
Total RNA from mouse tissues was extracted using Trizol
reagent according to the manufacturer’s protocol (Invitrogen),
followed by a cleanup procedure with RNeasy columns (Qiagen).
RNA from mouse islets as well as mouse pituitary and adrenal
gland was extracted using the Absolutely RNA microprep
(Stratagene). For MIN6 and INS1-832/13 cells, we used the
PureLink micro-to-midi RNA kit (Invitrogen). The total RNA
quantity and quality was determined using the NanoDrop ND-
1000 spectrophotometer (NanoDropTechnologies) and the 2100
Bioanalyzer (Agilent, Germany), respectively. Total RNA profiles
of all tested samples were similar with sharp 18S and 28S rRNA
peaks on a flat baseline. Poly(A)
+-RNA was isolated from INS-1E
cells as described [34]. For microarray, total cellular mRNA (2 mg,
except for islets, adrenal gland and pituitary where 1 mg was used)
was reverse transcribed into cDNA (SuperScript Choice System,
lnvitrogen, using oligo-dT primers and a T7 RNA polymerase
promoter site). In all cases the cDNA was in vitro transcribed and
biotin-labeled for microarray analysis using a commercially
available kit (Affymetrix IVT labeling kit, CA). The concentration
of labelledcRNA was measured using the NanoDrop ND-1000
spectrophotometer. Labeled cRNA was fragmented in a fragmen-
tation buffer during 35 min at 94uC. The quality of labeled and
fragmented cRNA was analyzed using the Agilent bioanalyzer
2100. Fragmented cRNA was hybridized to the mouse 430 2.0
(Affymetrix) array during 16 h at 45uC. Washing and staining of
the arrays was performed in a fluidics station (Affymetrix) and
afterwards scanned with the Affymetrix 3000 GeneScanner. All
image files were analyzed using GCOS with the MAS 5 algorithm.
The fluorescence intensity of each individual chip was scaled to a
target intensity of 150 using the global scaling method. All quality
controls of the arrays were according to manufacturer’s criteria.
All data files have been deposited in the NCBI Gene Expression
Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/), are MIAME
compliantand are accessible through GEO series accession number
GSE24207.
For quantitative RT-PCR,1mg total RNA was reversed transcribed
with the RevertAid H Minus First strand cDNA synthesis kit
(Fermentas) or using GeneAmp RNA PCR (Roche). Targets were
amplified from 5 ngcDNA in a rotor-gene 3000 (Corbett Research)
with absolute QPCR mix (ABgene) or on a LightCycler (Roche)
with SYBR Green PCR master mix (Qiagen) using the following
oligonucleotide sequences: forward Mm_Ufm1,5 9-GGTGTGT-
GTCAGGCGGTTC-39; reverse Mm_Ufm1,5 9-CATTCCCAG-





forward beta-actin, 59-AGCCATGTACGTAGCCATCCA-39; re-
verse beta-actin, 59-TCTCCGGAGTCCATCACAATG-39; probe
beta-actin 59-(6-FAM) TGTCCCTGTATGCCTCTGGTCG-
TAC(BHQ1)-39; forward Rn_Ufbp1,5 9- GGAAGAAGTGGAT-
GAGAACGAGG-39; reverse Rn_Ufbp1,5 9- CCTGTTGGG-
TGAACTTCTGC-39; probe Rn_Ufbp1 59-(6-FAM) AGCTG-
CTGTTCCAGCCCAGGAGGAAGAAG(TAMRA)-39, forward
Rn_Ufl1, 59-CAAGGACTTACTTACAAGAAGAGGTTTC-39;
reverse Rn_Ufl1, 59-GGTACACACTGTCTTCAGC-39; probe
Rn_Ufl1, 59(6-FAM)CAGATGACACACAGACTGCTCTGAC-
CAAGC(TAMRA)-39. Primers for glyceraldehyde-3-phosphate
dehydrogenase (GAPDH), Chop,BiP and spliced XBP1 have been
reported before [34,53].
Plasmid construction and siRNA
Mouse Ufm1 was amplified by PCR using primers 59-
GTGCATATGTCGAAGGTGTCCTT-39 and 59-GAGGGAT-
CCTTAGCAGCTTCCAACTCG-39 for cloning in pET16 (Ndel/
BamHI), 59CGTAAGCTTCCATGTCGAAGGTGTCCTT-39
and 59-GCGAATTCTATTAGCAGCTTCCAACTCG-39 for
cloning in pcDNA3, eGFP(C1) and pmRFP(C1) (Invitrogen)
(HindIIl/EcoRI), 59-CCGAATTCCATGTCGAAGGTGTCCTT-
39 and 59-GAGGGATCCTTAGCAGCTTCCAACTCG-39 for
cloning in pEXPR-IBA105 (Westburg) (EcoRI/BamHI), 59-CG-
GGATCCATGTCGAAGGTGTCCTTTAA-39 and 59-GAGG-
GATCCTTATCCAACTCGGTCTCTAGG-39 for cloning in
pGEX-2TK (BamHI).Ufm1(G83A) was obtained via site-directed




PCI domain of Ufbp1 was removed by cloning of the Xbal/EcoRI
fragment of plasmid pEXPR-IBA103_Ufbp1_STrEP in the (Xhol/
EcoRI), resulting in the plasmid pEXPR-IBA103_Ufbp1
1–219_
STrEP. An eGFP tag was cloned in this construct via Xhol/AfIll
cloning, or removed by Xhol/AflIl digestion and Klenow fill in
reaction.Ufbp1withoutasignalpeptide(Ufbp1
29–314)wasgenerated
via PCR using primers 59-TGATCTAGAATGGCAGCAGCT-
GACGGAGAACC-39 and 59-GACCTCGAGGGCTGAAGC-
CTGGGCAGGGAG-39 for cloning in the pEXPR-IBA103 vector
(Xbal/Xhol).The STrEP-tag of this construct was replaced by eGFP
via Xhol/Aflll cloning, or removed via Xhol/AflIldigestion and
Klenow fill in reaction. The lysine mutants of Ufbp1 were obtained
via site-directed mutagenesis (Stratagene). Mouse Ufl1 was
amplified via PCR using primers 59-TGAAAGCTTCAATGGCG-
GACGCCTGGGAGG-39 and 59-GTAGAATTCTTATGCT-
CCTCTGTGACAGATGATTTCC-39, and cloned in pcDNA3
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CAATGCAGGACCATCAGCACG-39 and 59-GTAGAATTCT-
CACAGGACGGCCACTGTATCTC39, and cloned in pcDNA3
(HindIII/EcoRI). Cdk5Rap3 (HindIII/Klenow/EcoRI) from this
construct was cloned in pGEX-2TK (SmaI/EcoRI). Mouse BiP
was amplified using primers 59-TGAAAGCTTCAATGATGA-
AGTTCACTGTGG-39 and 59-GACCTGCAGACAACTCAT-
CTTTTTCTGATGTATCC-39, and cloned in pcDNA3 (Hin-
dIII/PstI).The plasmid pCI-NeoHA-CD3delta was a kind gift of Dr.
A. Weissman [54].
ONTARGETplusUfm1siRNA (Dharmacon) against the rat
Ufm1 sequence 59-GUUUGCAGAAGAGUUUAA-39 or 59-




ing rat Ufbp1 (Dharmacon) or (59-AGUAAACAUUGUCGA-
CUUAUU-39,5 9-GAACAUGGGUUGACGUUUCUU-39,5 9-
UGUUGUGGUCAGCGAGAAAUU-39,5 9-AAGACAGUGU-
GUACCGAUAUU-39) targeting rat Ufl1 were used. A non-
targetingsiRNA or pool was used as negative control (Dharmacon
or Qiagen).
Antibodies
Polyclonal UFM1 and UFBP1 specific antibodies were raised
against the recombinant His-tagged UFM1 and the UFBP1
peptide C-RKRLESQREAEWKKE (synthesised by EZbiolab),
respectively. The UFBP1 peptide was conjugated with maleimide-
activated mcKLH following the manufacturer’s protocol (Pierce).
Rabbits were immunized with antigen (His_UFM1 or UFBP1
peptide_KLH) in Freund’s complete adjuvant and boosted after
14 days using Freund’s incomplete adjuvant. Serum was affinity
purified using CNBr-activated sepharose 4 fast flow beads
(Amersham) linked with recombinant His-UFM1 or UFBP1
peptide conjugated to BSA. GST antibody was from Santa Cruz,
BiP, b-actin and GAPDH antibody from Abcam, HSPA8
antibody from Gentaur, LAMP2 and HA antibody from Sigma
and GDH antibody was a kind gift from M. Franssen (K.U.
Leuven, Belgium). BiP and UFBP1 antibodies were conjugated to
HRP using the ‘lightning-link HRP conjugating’ kit (Innova
Biosciences) for detection after immunoprecipitation.
Protein isolation, subcellular fractionation and
immunoprecipitation
For total protein extraction, tissues were immediately washed
with PBS after dissection and lysed in S1 buffer (50 mMTris,
pH 8; 0.4% NP-40; 150 mMNaCl; 1 mM EDTA; proteinase
inhibitor cocktail tablet (Roche); 1 mM PMSF; 2 mM N-
ethylmaleimide), using a pestle for homogenization. Protein
concentrations were measured via Dc protein assay (Bio-Rad).
For subcellular fractionation, MIN6 cells were homogenised in
freshly prepared HMB buffer (250 mM sucrose; 5 mM MOPS,
pH 7.2; 1 mM EDTA; 1 mM DTT; 1 mM PMSF; 2 mM N-
ethylmaleimide; proteinase inhibitor cocktail tablet) with a metal
douncer (20 strokes). The homogenate was centrifuged at 7706g
for 10 min. The pellet (N) was resuspended in 1 ml HM buffer.
The supernatant was centrifuged for an additional 10 min at
23306g. The pellet (M) was again resuspended in 1 ml HMB
buffer, and the supernatant centrifuged at 130006g for 20 min.
The resulting pellet (L) was resuspended in 1 ml HM buffer and
the supernatant centrifuged at 1000006g for 60 min. After
resolving the pellet (P) in 1 ml HM buffer and bringing the
supernatant (S) volume to 1 ml, all the protein fractions were
precipitated with 7% TCA and 0.015% deoxycholate. The pellets
were resolved in SDS sample buffer. Protein extracts were
separated by 4–12% SDS-PAGE (Invitrogen).For co-immunopre-
cipitation, cell lysates were incubated with BiP, UFBP1 or UFM1
antibody and bound to protein A-TSK sepharose (Affiland). After
elution, proteins were separated by SDS-PAGE and detected via
immunostaining.
GST protein isolation, in vitro transcription/translation
and GST pull down assay
GST protein isolation. E. coli pLYS cells were used to produce GST
and GST-Ufm1 recombinant protein. 1 mM IPTG was used to
induce protein expression at 30uC for 2 hours. Bacterial cells were
resuspended in lysis buffer (50 mMTris,pH 7.5; 0.45 M NaCl; 0.1%
Triton-X-100; 1 mM DTT; 0.1% b-mercaptoethanol) and disrupted
by sonication (66100). After centrifugation (120006g, 20 min), the
protein extracts were immobilized on glutathione-agarose beads
(Sigma)for1 hourat4uC.The beads were then washed with washing
buffer (50 mMTris, pH 7.5; 0.15 M NaCl; 0.1% Triton-X-100;
1 mM DTT; 0.1% b-mercaptoethanol). The GST fusion proteins
were eluted from the beads with reduced glutathione (Acros) in
100 mMTris, pH 7.5, and after concentration, dialysed overnight in
PBS +500 mMNaCl.In vitro transcription/translation.T h eT n TT 7
transcription/translation kit (Promega), using rabbit reticulocyte
lysates, was used to prepare in vitro
35S-methionine labeled target
proteins, following the manufacturer’s protocol.GST pull-down assay.
100 ml glutathione-agarose beads were blocked in Tris-buffer
(50 mMTris, pH 7.5; 100 mMNaCl)+1m g / m l B S A a n d 0 . 5 %
Triton-X-100 for 15 min at 4uC. After washing and resuspending
the beads with binding buffer (50 mMTris, pH 7.5; 100 mMNaCl,
0.1% NP40; 1 mM DTT), they were incubated with 550 pmol GST
protein or GST-Ufm1 protein for 30 min at 4uC. The beads were
then washed 2 times with binding buffer and resuspended in 50 ml
binding buffer. MIN6 cell-lysates and
35S-labelled proteins (40 ml)
were pre-cleared on GST coupled beads for 30 min at 4uC. 40 ml
coupled beads were incubated with 10 ml pre-cleared MIN6 lysates
(25610
3 cells) and 1/3 pre-cleared
35S-labelled protein in ubiquitila-
tion buffer (50 mMTris, pH 7.5; 100 mMNaCl, 0.1% NP40; 1 mM
DTT; 2 mM ATP; 5 mM MgCl2)( f i n a lv o l u m e ,2 0 0ml) for 30 min
at 40uC. The beads were then washed 3 times with binding buffer.
Bound proteins were released from the beads by boiling in SDS
sample buffer and separated on a 4–12% Tris-Glycine gel in MES
buffer. The gel was dried and analyzed via phosphorimaging.
Apoptosis
The percentage of viable, apoptotic, and necrotic cells was
determined following staining of INS-1E cells with the DNA
binding dyes propidium iodide and Hoechst 33342, as described
[50]. For caspase 3 cleavage measurements, cells were washed
with cold PBS and lysed with Laemmli buffer. Lysates were then
resolved by 15% SDS-PAGE and transferred to a nitrocellulose
membrane. Cleaved caspase-3 (Asp175, Cell Signaling, 1/1000)
and a-tubulin (Sigma, (1/5000) were used as primary antibodies.
Horseradish-peroxidase-labeled rabbit and mouse antibodies
(Thermo Scientific) were used as secondary antibodies. Immuno-
reactive bands were revealed using the SuperSignalH West
Femtochemiluminescent substrate (Thermo Scientific), detected
using a LAS-3000 charge-coupled device camera and quantified
with the Aida Analysis software (Fujifilm).
Insulin release
Cells were treated with duplexes as described and grown to
confluency. Insulin secretion was assayed as previously described
[47]. Briefly, cells were washed with HEPES balanced salt solution
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1.16 mM MgSO4, 20mM HEPES, 2.5 mM CaCl2, 25.5 mM
NaHCO3 and 0.2% BSA, pH7.2) with 3 mM glucose followed by
a 2 hour pre-incubation in the same buffer. For glucose-stimulated
insulin secretion, cells were incubated in HBSS for an additional
2 hours in the presence of 3 mM, 15 mM glucose or 15 mM
glucose+30 mMKCl as indicated followed by collection of buffer
for insulin radioimmunoassay (Coat-A-Count kit, DPC).
STrEP-tag affinity purification and mass spectrometry
STrEP-tag affinity purification.150610
6 MIN6 cells were transfect-
ed with STrEP_Ufm1or Ufbp1_STrEP for 72 hours. After total
protein extraction in S1 buffer, lysates were incubated with
STrEP-Tactin beads (Westburg), following the manufacturer’s
protocol. The affinity purified proteins were separated on a 4–12%
Tris/Glycine gel (Invitrogen) and stained with coomassie. The
proteins that were present in the UFM1 purified samples and not
in the control were picked for analysis via mass spectrometry.Mass
spectrometry.Gel bands were picked in water, transferred to 100 ml
fixation solution (50% methanol; 5% acetic acid) and rinsed three
times with water and three times with ACN (LC-MS quality,
chromasolv, Sigma). The gels were hydrated in 100 mM
NH4HC03, followed by dehydration in 100% ACN, each
10 min. This step was repeated twice prior to dehydrating the
gel pieces in a speedvac. Gel pieces were rehydrated in digestion
buffer (50 mM NH4HCO3; 5 mM CaCl2), containing 1 ng/ml
modified trypsin (Promega) and incubated overnight at 37uC. The
resulting peptides were extracted from gel in four steps: once with
50 mM NH4HCO3, twice with 50% ACN; 5% formic acid and
once with 95% ACN; 5% formic acid, each 30 min. Supernatants
were dried in a speedvac. Upon concentrating and desalting the
tryptic fragments using Millipore C-18 ZipTips, the samples were
mixed in a 1/1 v/v ratio with alpha-cyano-4-hydroxy-cinnamic
acid matrix (saturated solution in 50% ACN; 2.5% TFA in HPLC
water), spotted onto the MALDI target plate and allowed to air
dry. MS/MS analysis was performed on a 4800 MALDI TOF/
TOF (Applied Biosystems). The instrument was calibrated with
the Applied Biosystems Calibration Mixture 1. Measurements
were taken in the positive ion mode between 900 and 9000 m/z.
Sequences were automatically acquired by scanning first in MS
mode and selecting the 15 most intense ions for MS/MS using an
exclusion list of peaks arising from trypticautodigestion. Data
interpretation was carried out with the GPS Explorer software
(V3.5) and database searching with the Mascot program (version
2.0.00). MS/MS searches were conducted with the following
settings: MS/MS tolerance for precursor and fragment ions
between 0.2 and 1 Da depending on the sample, methionine
oxidation as variable modification and carbamidomethylation of
cysteine as fixed modification. Trypsin was selected as enzyme and
a maximum of one missed cleavage was allowed. Using these
parameters the probability-based MOWSE score greater than the
given cut-off value for MS/MS fragmentation data were taken as
significant (p,0.05).
Pulse/chase
Cells were pre-incubated for 1 hour in starving medium (RPMI
1640 without cystine and methionine (Sigma)) and then labeled
with 200 mCi
35S-methionine/cysteine (Perkin Elmer Easytag
express protein labeling mix, specific activity 1175 Ci/mmol) for
1 hour at 37uC, followed by a 0, 30, 60 and 90 min chase at 37uC.
The cell lysates were immunoprecipitated using HA antiserum
(Sigma) and bound to protein A-TSK sepharose (Affiland). After
elution, proteins were separated by SDS-PAGE and quantified for
autoradiographic signals using ImageQuant software.
Laser scanning confocal microscopy
Transfected INS1-832/13 cells were incubated with 1 mM ER-
tracker blue-white DPX (Invitrogen), to stain the ER. Images were
obtained with a Zeiss LSM510 laser scanning confocal micro-
scope, using a 636oil objective.
Supporting Information
Figure S1 mRNA expression of Ufm1 in different mouse
tissues, measured via QPCR and normalised for b-actin.
Data are means6SD, n$3.
(TIF)
Figure S2 Coomassie staining of the different fractions
during STrEP-tag affinity purification of UFM1 (A) and
UFBP1 (B). Together with the eluate samples, a small aliquot was
taken from the protein extract before and after binding to the beads
and from the wash step. MIN6 cells were transfected with empty
vector (E) or with a vector containing STrep-Ufm1 (U). Two
different molecular weight markers were used. The protein
fragments used for MS/MS identification are indicated and
numbered. The identification of the proteins of UFM1 purification
is shown in table 1, B Three distinct bands were shown to contain
the UFBP1 protein. Fragment 1: the presence of both UFBP1 and
G3P (glyceraldehyde 3-phosphate dehydrogenase, mass: 35810 Da)
was demonstrated. The tryptic peptide containing the unmodified
K268 (sequence: IQDLLTEGTLTGVIDGGK, mass: 2044 Da) in
UFBP1 was measured with confidence (delta mass of 0.01 Da). Also
the tryptic peptide following the K268 residue (sequence:
FIYITPEELAAVANFIR, mass: 1967 Da) was demonstrated with
confidence (delta mass: 0.04 Da), supporting the idea K268 is not
modified and thereby excluded as a trypsin-cleaving site. Peptide
fragmentation data was generated by MS/MS analysis and
confirmed the peptide identities. Fragment 2: this band is identified
as UFBP1. Again the 2044 (delta: 0.01 Da) and the 1967 (delta:
0.04 Da) masses were present. MS/MS analysis confirmed the AA
sequences. The elution position in the SDS-PAGE gel corresponds
to the expected molecular weight of the native protein (35956 Da).
Fragment3:Twoproteinswereidentified:PDIA6(protein disulfide-
isomerase A6) and UFBP1. The position in the SDS-PAGE gel fits
perfectly with the mass of PDIA6 (48070 Da) but is about 10 kDa
too high for UFBP1. However, it is in perfect agreement with a
UFM1 modification (+9.1 kDa) of UFBP1. Remarkably, both
peptides (2044 and 1967), reporting the unmodified K268, are now
missing, C Cellular fractionation of MIN6 cells overexpressing
UFBP1_eGFP+UFM1 (left panel) or UFBP1K268R_eGFP+UFM1
(right panel). *=UFBP12UFM1 conjugate, r=UFBP1-eGFP2
UFM1 conjugate.
(TIF)
Figure S3 UFBP1 and UFM1 are co-localized in the ER.
A HeLa cells transfected or co-transfected with different eGFP or
mRFP constructs as indicated on the picture, B INS1 cells co-
transfected with mRFP-UFM1 and UFBP1-eGFP as depicted.
Cells were also stained with an ER-tracker (blue). Pictures were
taken with a 636objective on a Zeiss confocal microscope.
(TIF)
Figure S4 Cellular localization of UFM1 and UFBP1. A
INS1-832/13 cells transfected with wild type UFM1 or
UFM1
G83A, they both show similar localization. B INS1-832/13
cells co-transfected with UFM1 (WT or G83A-mutant) and
UFBP1 (WT or K268R-mutant) as depicted on the picture. Cells
were also stained with an ER-tracker (blue). Pictures were taken
with a 636objective on a Zeiss confocal microscope.
(TIF)
Role of UFBP1 and UFM1 during ER Stress
PLoS ONE | www.plosone.org 12 April 2011 | Volume 6 | Issue 4 | e18517Figure S5 Insulin secretion is not affected by Ufm1 or
Ufbp1 silencing. INS1-832/13 cells were silenced with Ufm1
(black bars) or Ufbp1 (grey bars) specific siRNA or with non-target
siRNA (white bars). 48 hours after transfection, cells were
incubated in medium with low (G3) or high (G15) glucose
concentrations, or with high glucose concentrations together with
30 mMKCl. Data are means6SD, n=4.
(TIF)
Figure S6 Ufm1 and Ufbp1 mRNA expression during
apoptosis experiment of Figure 5. Expression was normal-
ized to GAPDH (Ufm1 and Ufbp1)o rb-actin (Ufl1) expression.
Data are means6SEM.
(TIF)
Figure S7 ER stress markers are not enhanced after
Ufm1 or Ufbp1 silencing. INS-1E cells were transfected with
siRNA against Ufm1, Ufbp1 or non-target siRNA and treated with
oleate, palmitate or CPA for 14 hours. mRNA expression of BiP,
Chop and Xbp1 splicing were analyzed using qPCR, and
normalized for GAPDH. Data are means6SEM with n$5,
paired student t-test: *, p#0.05; .**, p#0.01; ***, p#0.005.
(TIF)
Figure S8 UFBP1 plays a role in ERAD. \ERAD activity
was analyzed by measuring CD3d degradation in INS1-832/12
cells transfected with siRNA against Ufm1,Ufbp1 andUfl1
and24 hours later with a CD3d-HA expression construct, A
Silencing of Ufm1 and Ufbp1 was analyzed via qPCR, B The
transfected were starved for 1 hour and labeled with
35S-Met-Cys
for 1 hour. After 0, 30, 60 and 90 min chase, cells were lysed and
CD3d-HA was immunoprecipitated with an HA antibody. After
SDS-PAGE (upper panel), CD3dwas quantified (lower panel) and
normalized for total
35S incorporation. Data are means6SEM,
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